PeptideStack
5.2kquestions
20kanswers
220users

Is 0.5 mg weekly a defensible maintenance dose for ecnoglutide?

Asked 11 Feb 2026Modified 6 months agoViewed 4.3k times
27

The particulars: 0.5 mg · ecnoglutide.

I am at the decision point and I would rather think it through than improvise.

I would rather spend money on measurement than on redundancy.

What does a sensible plan look like, and what are the decision points?

maintenance-dose
maintenance-dose

Staying put: the lowest dose that holds a result, the difference between the maximum studied dose and the maximum useful dose, and what the…

54 questionsclinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsdosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questionsecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
shareeditfollowflag
LM
askedlucia_marchetti19k2711 Feb 2026
6How long since the last increase? That is the first thing anyone will ask. – lyoph_cake 9 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 4.3k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.